Haemonetics announces acquisition of Global Med Technologies

Haemonetics revealed this week that it plans to buy Global Med Technologies.

The firm will pay approximately $60 million (37.57 million pounds) for the organisation, a sum based on Global Med’s 49 million diluted common equivalent shares outstanding.

Operating in the information technology sector, the company supplies software solutions and services for a wide range of organisations, including those dealing in blood collection hospital transfusions and patient care.

Global Med’s European subsidiary, Inlog SA, is a developer of donor centre and transfusion management systems, cellular therapy software and laboratory information systems.

According to Brian Concannon, president and chief executive officer of Haemonetics, this is a key area that will serve to complement the group’s existing offerings.

“Haemonetics is the only company positioned to address the needs of both the blood collection and transfusion markets,” he explained.

In November, the organisation published its financial results for the second quarter of fiscal 2010 – revealing that its net revenues reached $157 million during the period.